Stockreport

Merck Walks Away: What The Failed Acquisition Means For Revolution Medicines [Seeking Alpha]

Revolution Medicines, Inc.  (RVMD) 
PDF RVMD's valuation is extremely elevated, trading at 25,000x trailing sales, driven by takeover speculation and high expectations for daraxonrasib. Upcoming Phase 3 rea [Read more]